Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Daiichi Sankyo
Daiichi Sankyo
Korea University Guro Hospital
Taproot Health
Mabwell (Shanghai) Bioscience Co., Ltd.
Capital Medical University
ARCAGY/ GINECO GROUP
Genelux Corporation
Xi'an Jiaotong University